Literature DB >> 29545694

Effect of increased functional residual capacity on the active range of thoracic axial rotation in healthy young men.

Akira Kubo1, Masahiro Ishizaka1, Yoshiki Takeuchi1,2, Keita Shimura3.   

Abstract

[Purpose] To understand the effect of increased functional residual capacity (FRC) on the active range of thoracic axial rotation (AROTAR) in healthy young men.
[Subjects and Methods] Thirty-nine right-handed healthy male volunteers (age=20.1 ± 1.6 years) participated in this study. A standard plastic goniometer was used to measure the AROTAR in the supine position with both glenohumeral joints fully flexed. AROTAR was recorded at the resting expiration level (REL) and for 4 different FRC levels: 500, 1,000, 1,500, and 2,000 ml air inhaled at REL. FRC volumes and laterality were analyzed using a two-way repeated measure of ANOVA and post-hoc analysis. Relationships between the relative value (AROTAR for each increased FRC level / REL AROTAR × 100) and AROTAR for each increased FRC level were analyzed using Pearson's correlation coefficient.
[Results] A significant main effect was found for only FRC factor. AROTAR had a positive moderate correlation with relative value. The correlation coefficient was higher than 0.5 for in 1,500 and 2,000 ml.
[Conclusion] An increase in FRC might decrease AROTAR and if the REL AROTAR is high, the decrease in AROTAR due to increased FRC is lesser. It is suggested that maintaining the thoracic mobility could minimize a COPD patient's AROTAR limitation and maintain physical ability.

Entities:  

Keywords:  COPD; Functional residual capacity; Range of thoracic axial rotation

Year:  2018        PMID: 29545694      PMCID: PMC5851363          DOI: 10.1589/jpts.30.282

Source DB:  PubMed          Journal:  J Phys Ther Sci        ISSN: 0915-5287


INTRODUCTION

Chronic Obstructive Pulmonary Disease (COPD) is a major public health problem. By 2020, COPD is predicted to be the third1) and fifth2) leading causes of death in the world. Poor thoracic mobility is one of the major disabilities in patients with COPD. The disease severely affects their ability to perform activities of daily living and their quality of life. The causes and mechanisms for poor thoracic mobility in these patients are complicated. The poor mobility causes respiratory parameters such as increased functional residual capacity (FRC). Thus, the degree of increase in FRC is an important indicator of the severity of COPD, and the active range of thoracic axial rotation (AROTAR) is an important parameter during routine clinical assessment of patients with COPD. In general, adequate AROTAR is essential for sports activities such as golf, throwing, and tennis. Although movement of the vertebrae can be more accurately measured by diagnostic imaging, this is not widely used in clinical practice because of the associated cost and potential radiation exposure3, 4). Clinically, AROTAR has been measured by visual estimation and the use of a goniometer or inclinometer5, 6). Johnson et al. described techniques such as seated rotation technique, half-kneeling technique, and lumbar-locked rotation technique to measure AROTAR. However these positions are inapplicable in COPD patients, because they require the trunk to be in an upright position. Little has been published on the assessment of AROTAR in the supine position. Kudo et al.7) reported Wing-test (W-t) as a measurement technique for the rib cage-hip joint flexibility of axial rotation in the supine position. Therefore, we considered that W-t could be used for the measurement of AROTAR in patients with COPD. The purpose of the present study was to understand the effects of increased functional residual capacity (FRC) on AROTAR using the modified wing test (mW-t) to measure the rib cage-hip joint flexibility, included the influence by laterality in healthy young men. The reason for recruiting healthy young men was to exclude the bias due to general health status (malnutrition, systemic inflammation), physical activity level, quality of life, and age-related changes in physical conditions.

SUBJECTS AND METHODS

Thirty-nine right-handed healthy male volunteers (age=21.6 ± 1.6 years, height=172.9 ± 5.9 cm, mass=65.7 ± 9.4 kg, body mass index=21.9 ± 2.6 kg/m2) participated in this study. The participants were recruited from a university. Exclusion criteria were any pathologic condition of the spine, rib, shoulder, hip, or knee within the past 6 months, a history of scoliosis, or the presence of spinal deformation, and a rheumatologic or respiratory condition at the time of study. All volunteers signed an informed consent form that was approved by the institutional review board at the university of the corresponding author (Approval No. 2015-Io-6). This study involved a descriptive laboratory design, which has been described in previous articles7,8,9). Kim et al. suggested that thoraco-lumbo-pelvic rotation in supine position as leg lateral reach test and showed good reliability. To measure AROTAR, the participant was in a supine position with both glenohumeral joints fully flexed8). In this position, one examiner stood at the cranial end and fixed both sides of scapula of the participant. One foot of the participant remained on the bed and the contralateral hip and knee joints were flexed at 90 degrees. The participant then maximally rotated his trunk to the opposite side. Another examiner measured the angle from the lines between the thigh and perpendicular to the floor (Fig. 1). A standard plastic goniometer was used to measure AROTAR. The required time was about 5 seconds after inhalation per trial. This testing position was selected because it is commonly used in the clinical setting.
Fig.1.

Measurement of the active range of thoracic axial rotation (AROTAR).

Measurement of the active range of thoracic axial rotation (AROTAR). The AROTAR in both right and left directions was recorded at resting expiration level (REL) and at four different FRC levels, that is, 500, 1,000, 1,500, and 2,000 ml air inhaled at REL from a 2,000-ml capacity rounded cylinder (ACA105, MINATO MEDICAL SCIENCE Co., Ltd, Tokyo). All AROTAR measurements were performed in a randomized order. We modified the W-t of Kudo et al.7, 8) such that it described the results from a distance to angle. The distance from the contact surface of the back to medial surface of the thigh was changed to the angle from the lines between the thigh and perpendicular to the floor. Statistical analysis of the results was carried out using SPSS for Windows 23.0 (IBM Corporation). Descriptive data are expressed as mean ± standard deviation. The FRC level and laterality were analyzed using a two-way repeated measure of ANOVA, and post-hoc analysis was carried out using Bonferroni’s method. Relationships between relative value (AROTAR for each increased FRC condition / REL AROTAR × 100) and AROTAR for each increased FRC condition were analyzed using Pearson’s correlation coefficient. P<0.05 indicated statistical significance.

RESULTS

The AROTARs of both sides under the five circumstances are shown in Table 1. A significant effect was found in only FRC factor and no significant interaction was found in other condition.
Table 1.

AROTAR in five different conditions of both sides

REL(2)(3)(4)(5)500 ml(l)(4)(5)1,000 ml(l)(5)1,500 ml(l)(5)2,000 ml(1)(2)(3)(4)
(1)(2)(3)(4)(5)
Rt (°)64.4 ± 15.259.9 ± 14.859.0 ± 13.856.5 ± 15.452.7 ± 14.5
Lt (°)61.3 ± 13.658.2 ± 13.355.1 ± 14.254.4 ± 14.152.6 ± 14.8

Data are mean ± SD.

Superscripts indicate significant differences between the groups (p<0.05).

REL: resting expiration level; Rt: right; Lt: left.

Data are mean ± SD. Superscripts indicate significant differences between the groups (p<0.05). REL: resting expiration level; Rt: right; Lt: left. The AROTAR was significantly decreased for FRCs of 500, 1,000, 1,500, and 2,000 ml compared to REL level, 1500 and 2,000 ml compared to 500 ml level, 1,000 compared to 2,000 ml level, and 1,500 compared to 2,000 ml level. Pearson’s correlation coefficient of relative value (AROTAR for each increased FRC level/REL AROTAR × 100) in right and left AROTAR for each increased FRC level is shown in Table 2. AROTAR at 500, 1,500 and 2,000 ml FRC, to right side had a positive correlation from weak (r=0.34, p<0.05) to moderate (r=0.51–0.52, p<0.01) level, with relative value and in 1,000, 1,500 and 2,000 ml conditions to left side had a positive moderate correlation (r=0.52–0.60, p<0.01) with relative value. The correlation coefficient was more than 0.5 for FRCs of 1,500 and 2,000 ml, on both sides.
Table 2.

Pearson’s correlation coefficient of relative value

500 ml1,000 ml1,500 ml2,000 ml
Rt0.34*0.300.51**0.52**
Lt 0.310.53**0.52**0.60**

(AROTAR in each increased FRC condition / REL AROTAR × 100) with items in Rt and Lt AROTAR in each increased FRC condition of 39.

*p<0.05, **p<0.01 based on Pearson’s correlation test.

Rt: right; Lt: left.

(AROTAR in each increased FRC condition / REL AROTAR × 100) with items in Rt and Lt AROTAR in each increased FRC condition of 39. *p<0.05, **p<0.01 based on Pearson’s correlation test. Rt: right; Lt: left.

DISCUSSION

The purpose of the present study was to understand the effect of increased FRC on AROTAR, using the mW-t as a measure of rib cage-hip joint flexibility included the influence by laterality in healthy young men. The results revealed a decrease in AROTAR with increase in FRC. As the correlation coefficient was greater than 0.5 for FRCs of 1,500 and 2,000 ml, if the AROTAR in REL is high, the reduction in AROTAR due to increased FRC would be lesser. No significant interaction was found, and there was no difference between the left and right sides. The poor mobility of trunk flexion due to the increased FRC may be limited by anatomical and physiological muscle chain. Furthermore, an expansion of the thorax by increasing of FRC leads to decreased mobility of the trunk rotation. An increased FRC, increased muscle activity to assist respiration, and aging effects in patients with COPD, leads to poor flexibility of all body muscles and joints, including the rib cage. It is considered that these factors simultaneously affect trunk mobility. In this study, the participants were healthy young men. Thus, this is the first study to demonstrate decreased AROTAR with a quantitative increase in FRC. French et al.10) evaluated the inspiratory capacity (IC)/total lung capacity (TLC) ratio and its association with survival rate. Using the IC/TLC ratio of ≤25%, as a representation of static lung hyperinflation, they were able to demonstrate that the IC/TLC ratio correlated with the risk of death in patients with an emphysematous phenotype of COPD. The use of the IC/TLC ratio, as a single predicting variable in patients with COPD, will allow clinicians to evaluate risk stratification of patients with the emphysematous phenotype of COPD. In our study, four different volumes of inhaled air (500–2,000 ml) from REL were set to increase the FRC. Under these circumstances the IC/TLC ratio is decreased. However, the IC/TLC ratio was not evaluated because the measurement of IC and TLC using spirometry was not conducted in our study. This is a limitation of this study, and further research on this is necessary. Physical therapists need tools to assess AROTAR and to monitor changes in AROTAR for effective physical therapy. Among the non-invasive methods for measuring ROM, a three-dimensional (3D) motion analysis system using stick pictures and electromagnetic tracking systems are excellent technological devices, but they are expensive and require considerable space. On the other hand, goniometric methods are convenient and economical. These findings provide physical therapists with specific measurement criteria for clinically relevant techniques, which can be applied using simple equipment and through training. The main limitation of this study is that all participants were healthy university male students. Future studies in a wider population, including patients with COPD, are necessary.

Conflict of interest

The authors report no conflicts of interest in this work.
  8 in total

1.  A comparative study of computed tomographic and plain radiographic methods to measure vertebral rotation in adolescent idiopathic scoliosis.

Authors:  E K Ho; S S Upadhyay; L Ferris; F L Chan; J Bacon-Shone; L C Hsu; J C Leong
Journal:  Spine (Phila Pa 1976)       Date:  1992-07       Impact factor: 3.468

2.  A comparison of four computerized methods for measuring vertebral rotation.

Authors:  G G Russell; V J Raso; D Hill; J McIvor
Journal:  Spine (Phila Pa 1976)       Date:  1990-01       Impact factor: 3.468

3.  Thoracic rotation measurement techniques: clinical commentary.

Authors:  Katherine D Johnson; Terry L Grindstaff
Journal:  N Am J Sports Phys Ther       Date:  2010-12

4.  Leg lateral reach test: The reliability and correlation with thoraco-lumbo-pelvic rotation range.

Authors:  Si-Hyun Kim; Oh-Yun Kwon; Kyue-Nam Park; Ui-Jae Hwang
Journal:  J Sci Med Sport       Date:  2016-05-02       Impact factor: 4.319

Review 5.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.

Authors:  Jørgen Vestbo; Suzanne S Hurd; Alvar G Agustí; Paul W Jones; Claus Vogelmeier; Antonio Anzueto; Peter J Barnes; Leonardo M Fabbri; Fernando J Martinez; Masaharu Nishimura; Robert A Stockley; Don D Sin; Roberto Rodriguez-Roisin
Journal:  Am J Respir Crit Care Med       Date:  2012-08-09       Impact factor: 21.405

6.  Reliability of thoracic spine rotation range-of-motion measurements in healthy adults.

Authors:  Katherine D Johnson; Kyung-Min Kim; Byung-Kyu Yu; Susan A Saliba; Terry L Grindstaff
Journal:  J Athl Train       Date:  2012 Jan-Feb       Impact factor: 2.860

7.  The inspiratory capacity/total lung capacity ratio as a predictor of survival in an emphysematous phenotype of chronic obstructive pulmonary disease.

Authors:  Aimee French; David Balfe; James M Mirocha; Jeremy A Falk; Zab Mosenifar
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-07-13

8.  Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010.

Authors:  Rafael Lozano; Mohsen Naghavi; Kyle Foreman; Stephen Lim; Kenji Shibuya; Victor Aboyans; Jerry Abraham; Timothy Adair; Rakesh Aggarwal; Stephanie Y Ahn; Miriam Alvarado; H Ross Anderson; Laurie M Anderson; Kathryn G Andrews; Charles Atkinson; Larry M Baddour; Suzanne Barker-Collo; David H Bartels; Michelle L Bell; Emelia J Benjamin; Derrick Bennett; Kavi Bhalla; Boris Bikbov; Aref Bin Abdulhak; Gretchen Birbeck; Fiona Blyth; Ian Bolliger; Soufiane Boufous; Chiara Bucello; Michael Burch; Peter Burney; Jonathan Carapetis; Honglei Chen; David Chou; Sumeet S Chugh; Luc E Coffeng; Steven D Colan; Samantha Colquhoun; K Ellicott Colson; John Condon; Myles D Connor; Leslie T Cooper; Matthew Corriere; Monica Cortinovis; Karen Courville de Vaccaro; William Couser; Benjamin C Cowie; Michael H Criqui; Marita Cross; Kaustubh C Dabhadkar; Nabila Dahodwala; Diego De Leo; Louisa Degenhardt; Allyne Delossantos; Julie Denenberg; Don C Des Jarlais; Samath D Dharmaratne; E Ray Dorsey; Tim Driscoll; Herbert Duber; Beth Ebel; Patricia J Erwin; Patricia Espindola; Majid Ezzati; Valery Feigin; Abraham D Flaxman; Mohammad H Forouzanfar; Francis Gerry R Fowkes; Richard Franklin; Marlene Fransen; Michael K Freeman; Sherine E Gabriel; Emmanuela Gakidou; Flavio Gaspari; Richard F Gillum; Diego Gonzalez-Medina; Yara A Halasa; Diana Haring; James E Harrison; Rasmus Havmoeller; Roderick J Hay; Bruno Hoen; Peter J Hotez; Damian Hoy; Kathryn H Jacobsen; Spencer L James; Rashmi Jasrasaria; Sudha Jayaraman; Nicole Johns; Ganesan Karthikeyan; Nicholas Kassebaum; Andre Keren; Jon-Paul Khoo; Lisa Marie Knowlton; Olive Kobusingye; Adofo Koranteng; Rita Krishnamurthi; Michael Lipnick; Steven E Lipshultz; Summer Lockett Ohno; Jacqueline Mabweijano; Michael F MacIntyre; Leslie Mallinger; Lyn March; Guy B Marks; Robin Marks; Akira Matsumori; Richard Matzopoulos; Bongani M Mayosi; John H McAnulty; Mary M McDermott; John McGrath; George A Mensah; Tony R Merriman; Catherine Michaud; Matthew Miller; Ted R Miller; Charles Mock; Ana Olga Mocumbi; Ali A Mokdad; Andrew Moran; Kim Mulholland; M Nathan Nair; Luigi Naldi; K M Venkat Narayan; Kiumarss Nasseri; Paul Norman; Martin O'Donnell; Saad B Omer; Katrina Ortblad; Richard Osborne; Doruk Ozgediz; Bishnu Pahari; Jeyaraj Durai Pandian; Andrea Panozo Rivero; Rogelio Perez Padilla; Fernando Perez-Ruiz; Norberto Perico; David Phillips; Kelsey Pierce; C Arden Pope; Esteban Porrini; Farshad Pourmalek; Murugesan Raju; Dharani Ranganathan; Jürgen T Rehm; David B Rein; Guiseppe Remuzzi; Frederick P Rivara; Thomas Roberts; Felipe Rodriguez De León; Lisa C Rosenfeld; Lesley Rushton; Ralph L Sacco; Joshua A Salomon; Uchechukwu Sampson; Ella Sanman; David C Schwebel; Maria Segui-Gomez; Donald S Shepard; David Singh; Jessica Singleton; Karen Sliwa; Emma Smith; Andrew Steer; Jennifer A Taylor; Bernadette Thomas; Imad M Tleyjeh; Jeffrey A Towbin; Thomas Truelsen; Eduardo A Undurraga; N Venketasubramanian; Lakshmi Vijayakumar; Theo Vos; Gregory R Wagner; Mengru Wang; Wenzhi Wang; Kerrianne Watt; Martin A Weinstock; Robert Weintraub; James D Wilkinson; Anthony D Woolf; Sarah Wulf; Pon-Hsiu Yeh; Paul Yip; Azadeh Zabetian; Zhi-Jie Zheng; Alan D Lopez; Christopher J L Murray; Mohammad A AlMazroa; Ziad A Memish
Journal:  Lancet       Date:  2012-12-15       Impact factor: 79.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.